Escalon Medical Corp. ESMC
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 50.22% | -24.92% | 11.51% | -3.81% | -25.97% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 50.22% | -24.92% | 11.51% | -3.81% | -25.97% |
| Cost of Revenue | 32.42% | -11.33% | 23.61% | -0.87% | -27.70% |
| Gross Profit | 73.14% | -40.83% | -1.14% | -7.62% | -23.64% |
| SG&A Expenses | 4.08% | 15.26% | 14.11% | 0.74% | 3.76% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 11.91% | -5.33% | 17.81% | 2.49% | -11.75% |
| Operating Income | 252.90% | -251.92% | -61.43% | -651.11% | -368.84% |
| Income Before Tax | 269.01% | 774.18% | -60.28% | -645.03% | -382.59% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 569.04% | 774.18% | -60.28% | -645.03% | -382.59% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 569.04% | 774.18% | -60.28% | -645.03% | -382.59% |
| EBIT | 252.90% | -251.92% | -61.43% | -651.11% | -368.84% |
| EBITDA | 257.35% | -246.17% | -59.67% | -1,093.87% | -330.46% |
| EPS Basic | 534.30% | 789.07% | -64.46% | -459.02% | -268.90% |
| Normalized Basic EPS | 269.06% | -262.01% | -60.39% | -648.15% | -383.19% |
| EPS Diluted | 529.96% | 789.07% | -64.46% | -241.00% | -268.90% |
| Normalized Diluted EPS | 184.38% | -258.33% | -61.47% | -648.15% | -383.19% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 100.31% | 2.43% | 2.43% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |